KD

Kevin Detrizio

Kevin Detrizio


Executive Director, Finance Strategic Planning & Initiatives



Professional Overview
Kevin Detrizio is an accomplished finance executive with extensive experience in the pharmaceutical industry. As the Executive Director of Finance Strategic Planning & Initiatives at Otsuka Pharmaceutical Companies (U.S.), he is responsible for driving strategic financial planning, leading cross-functional initiatives, and supporting the company's overall growth objectives.

Experience Summary

Current Role
In his current role, Kevin oversees the development and execution of Otsuka's finance strategic planning initiatives, focusing on optimizing financial processes, enhancing operational efficiency, and supporting key business decisions. He collaborates closely with cross-functional teams to identify and implement strategic initiatives that drive long-term value for the organization.

Career Progression
Prior to joining Otsuka, Kevin held various finance leadership positions at Bristol-Myers Squibb and Celgene. As the Executive Director of Finance at Bristol-Myers Squibb, he played a crucial role in the successful integration of Celgene's finance operations following the company's acquisition. In his previous roles at Celgene, Kevin served as the Senior Director and Director of Finance Strategic Initiatives, where he led the development and execution of strategic projects that improved financial reporting, enhanced profitability, and supported the company's growth objectives.

Earlier in his career, Kevin gained valuable experience as an Audit Manager at KPMG, where he provided audit and advisory services to clients in the pharmaceutical and healthcare industries.

Academic Background
Kevin holds a Bachelor of Science degree in Accounting from a prominent university. He is a Certified Public Accountant (CPA) and has completed several executive leadership development programs, further enhancing his strategic and managerial capabilities.

Areas of Expertise
  • Financial planning and analysis

  • Strategic initiatives and project management

  • Pharmaceutical industry expertise

  • Mergers and acquisitions integration

  • Financial reporting and control

  • Cross-functional collaboration and leadership


Professional Impact
Throughout his career, Kevin has demonstrated a track record of driving impactful financial initiatives and projects. At Bristol-Myers Squibb, he led the successful integration of Celgene's finance operations, ensuring a seamless transition and maximizing synergies. At Celgene, he spearheaded strategic initiatives that improved financial reporting, enhanced profitability, and supported the company's growth objectives.

Conclusion
With his extensive finance expertise, strategic mindset, and pharmaceutical industry knowledge, Kevin Detrizio is well-positioned to continue making a significant impact at Otsuka Pharmaceutical Companies (U.S.). He is committed to driving financial excellence, supporting the company's growth, and delivering innovative solutions that create long-term value for the organization and its stakeholders.